Insights On Drug Discovery

  1. Top 5 Cell Line Development Challenges (And How To Avoid Them) 11/6/2025

    The top five common cell line development pitfalls — scalability, stability, complexity, analytics, and tech transfer — can be avoided with experienced partners and integrated, predictive strategies.

  2. Optimize Your CLD With Innovative And Flexible Transposase Technology 11/6/2025

    To ensure speed and stability in the manufacture of your complex biologic — mAbs, antibodies, fusion proteins, and/or antibody drug conjugates — prioritize a high-performance CLD workflow.

  3. Achieve Speed, Stability, And Compliance In Cell Line Development 11/6/2025

    Partnering with a CDMO that demonstrates innovative and commercially validated cell line development capabilities is essential to protecting your market position and securing investor support.

  4. Smart Input Selection And Process Refinement For iPBMCs 11/5/2025

    Improved iPBMC manufacturing boosts TIL therapy reliability, safety, and affordability through donor screening, process refinements, and performance-based cell selection.

  5. Second Sourcing Is Natural ... Your Current CDMO Should Understand 9/23/2025

    Seasoned supply chain professionals say it is only natural to de-risk supply chains with sourcing materials and products at more than one external manufacturer ... no matter the insistence from the first external partner.

  6. Unlock The 3 Keys To Drug Discovery Success — Foresight, Hindsight, And Insight 9/13/2025

    If you don’t know where you are going, how will you get there? Articulating the destination of your therapeutic is essential for determining whether it is commercially viable and meets required milestones.

  7. Phenotypic Characterization Of Bleomycin-Induced Pulmonary Fibrosis Mod 9/8/2025

    To gain deeper biological insight, lung injury in this model has been further characterized through cellular phenotyping, gene expression analysis, and cytokine profiling.

  8. Decoding The Conformational Plasticity Of Ternary Complexes For Protacs' Differential Activity 9/8/2025

    Leverage our insights into PROTAC ternary complex plasticity and stability to accelerate the design of next-generation therapeutics.

  9. Scalable Production Of High-Purity Nanobodies Using Yeast Expression System 9/8/2025

    Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.

  10. Streptozotocin-Induced Diabetic Peripheral Neuropathic Pain Model 9/8/2025

    Emerging research highlights that insulin deficiency drives sensory neuropathy, and early insulin therapy may help prevent or alleviate chronic diabetic neuropathic pain.